FindTrial
Sign In

Effect of spot urine Na/K on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

Effect of spot urine Na/K on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024402
Enrollment
Unknown
Registered
2019-07-10
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast-induced acute kidney injury

Interventions

Case series:N//A

Sponsors

Zhongda Hospital of Southeast University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Volunteered to participate in this trial and signed informed consent; (2) Aged more than 18 Years; (3) Suspected as Coronary heart disease and Planned to execute Coronary angiography;

Exclusion criteria

Exclusion criteria: (1) Hypersensitivity to iodine-containing compounds; (2) CKD stages 5 (eGFR < 15ml/min per 1.73m2) or under Maintenance hemodialysis; (3) acute ST-segment elevation myocardial infarction (STEMI); (4) NYHA class IV or hemodynamic instability; (5) Take CT, MRI and other examinations with contrast agents during the two weeks before study; take radiographic examination of other contrast agents during the study period;

Design outcomes

Primary

MeasureTime frame
Primary Outcome Measures:The incedence of CI-AKI;spot urine Na/K;—

Countries

China

Contacts

Public ContactYan Gaoliang

Zhongda Hospital of Southeast University Medical School

yanshipingguo@163.com+86 18761890380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026